Tech Company Financing Transactions

Protembis Funding Round

Segulah Medical Acceleration, TechVision Fonds and XGen Ventures participated in a $32.4 million Series B funding round for Protembis. The funding round was announced on 3/26/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

Pauwelsstraße 17
Aachen, 52074
Germany

Phone

+49 (0) 241 99 03 36

Website

www.protembis.com

Email Address

[email protected]

Overview

At Protembis, we strive to develop a simple and reliable solution to protect patients from brain injury during left-sided heart procedures. With our product, the ProtEmbo® Cerebral Protection System -- already in its second generation -- it is our goal to improve patient quality of life and reduce overall healthcare costs associated with brain injury during those procedures.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Conrad Rasmus

        

Chief Executive Officer

Karl von Mangoldt

        

Chief Technical Officer

Oliver Schumacher

        

VP - Bus. Development

James Hallums

        

VP - Regulatory Affairs

Stefanie Brucker-Voigt

        

VP - Regulatory Affairs

Nawzer Mehta

        

Browse more venture capital transactions:

Prev: 3/26/2024: Gunzilla Games venture capital transaction
Next: 3/26/2024: Cyera venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary